This new complex of “PPARα-RORγ-SREBP2” explored a new mechanism on cholesterol reprogramming in a context and cell-type-specific manner, which would be beneficial for the invention of therapeutic strategy for MetS and related metabolic diseases. The gene discussed is RORC; the disease is metabolic syndrome.